Exosomes Secreted by the Cocultures of Normal and Oxygen–Glucose‐Deprived Stem Cells Improve Post‐stroke Outcome

Emerging stroke literature suggests that treatment of experimentally induced stroke with stem cells offered post-stroke neuroprotection via exosomes produced by these cells. Treatment with exosomes has great potential to overcome the limita- tions associated with cell-based therapies. 

Read More

Mesenchymal Stem Cell Treatment Prevents Post-Stroke Dysregulation of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases

Stem cell treatment is one of the potential treatment options for ischemic stroke. We recently demonstrated a protective effect of human umbilical cord blood-derived mesenchymal stem cells (HUCB-MSCs) in a rat model of ischemic stroke. 

Read More

Stem Cell Treatment After Cerebral Ischemia Regulates the Gene Expression of Apoptotic Molecules

Evidence suggests that apoptosis contributes significantly to cell death after cerebral ischemia. Our recent studies that utilized human umbilical cord blood- derived mesenchymal stem cells (hUCBSCs) demonstrated the potential of hUCBSCs to inhibit neuronal apoptosis in a rat model of CNS injury.

Read More


Stem Cell Therapy Decreases Covid Deaths

Several clinical studies report increased patient survival following the intravenous infusion of mesenchymal stem cells (MSCs) during the past year.  MSCs block the cytokine storm in the lungs and also regenerate cells and tissues damaged by the COVID-19 virus.  MSCs are not vaccines and work differently in the treatment of COVID-19. 

Read More

Stem Cell Activation by Natural Products

Bone marrow stem cell therapies, based on transplant of hematopoietic stem cells (HSCs) have been used for over 50 years in the treatment of blood disorders including leukemia, lymphoma, and auto-immune disorders. Embryonic stem cells (ESCs) were discovered in the late 1990’s by Evans, Kauffman, and Martin. J Thompson developed procedures to isolate and expand ESCs from human embryos. Since ESCs could differentiate into any cell in the body, this expanded application of stem therapy to include broad areas in disease treatment and regenerative medicine.

Read More

Comparison of Adipose Stromal Vascular Fraction and Placental Cell Extract

Multipotent mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including osteoarthritis and other conditions,

Read More


Comparative Analysis of Adult Mesenchymal Stem Cells

Mesenchymal stromal/stem cells (MSCs) have the potential to repair and regenerate damaged tissues, making them attractive candidates for cell-based therapies. Expanded and well-characterized MSCs have application in regenerative medicine and have been used in several clinical trials including treatment for osteoarthritis and other conditions. 

Read More

Stem Cell Therapy: The Good, the Bad & the Ugly

Recently the FDA issued permanent injunctions against stem cell clinics using a type of stem cell product called Stromal Vascular Fraction (SVF). This product (“The Bad”) is derived from fat retrieved from a patient by liposuction. It is then digested by enzymes, washed and filtered to yield SVF. It is injected back into the patient receiving the liposuction for various therapies. 

Read More

Anti-Aging Effects of AlloRx Stem Cell Therapy & Stemulife

As we age, our cells get sick and die. When a cell dies, it creates a cascade of events, leading to inflammation and disease that can decrease lifespan. Many environmental factors accelerate aging such as stress, pollution, lifestyle, injuries, disease, and exposure to toxins. A recently published study reviewed evidence that delaying and reversing aging in cells is feasible. Epigenetic changes drive aging and reversal of these changes extend lifespan1.

Read More